Duloxetine: uses, dosing, side effects & brands

Duloxetine hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor (SNRI).

The FDA classifies duloxetine as a serotonin and norepinephrine reuptake inhibitor. SNRIs slow the reabsorption of two brain chemicals, serotonin and norepinephrine, back into nerve cells. This leaves more of both available in the gaps between neurons to keep signaling, which can improve mood, anxiety, and certain types of chronic pain. If you are checking whether it is safe to combine with something else, the class is what matters — two drugs from the same class usually should not be stacked.

The label's §8.1 Risk Summary says published data and a postmarketing cohort study have NOT identified a clear drug-associated risk of major birth defects or other adverse developmental outcomes. However, it names specific risks: use in the month before delivery may be associated with an increased risk of postpartum hemorrhage, and neonates exposed to duloxetine (and other SNRIs/SSRIs) late in the third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding (respiratory distress, apnea, seizures, temperature instability, feeding difficulty, hypoglycemia, jitteriness, irritability), consistent with a toxic effect or drug-discontinuation syndrome. The label also stresses the risks of untreated depression, noting women who stop antidepressants in pregnancy are more likely to relapse. Any decision to start, stop, or change treatment during pregnancy should be made with the prescriber. This is what duloxetine's FDA label says; whether to use it in pregnancy is your prescriber's decision.

The label reports weight change in BOTH directions rather than a single effect. In adults, the adverse-reaction listing shows both 'weight increased' and 'weight decreased' as frequent. In pediatric trials, decreased weight is a common adverse reaction, and the label directs regular weight and growth monitoring in pediatric patients.

The label warns about alcohol, but the mechanism is liver injury, not a disulfiram reaction or sedation. It states that using duloxetine concomitantly with heavy alcohol intake may be associated with severe liver injury, and that duloxetine should not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease. The patient information explicitly advises avoiding heavy alcohol use while taking the drug. Notably, the label adds that in interaction studies duloxetine did NOT increase the impairment of mental and motor skills caused by alcohol, so the concern is hepatic, not additive CNS impairment. This is what duloxetine's FDA label says; alcohol advice depends on your dose and health, so confirm with your pharmacist.

The label has a section titled Discontinuation Syndrome. It reports that after abrupt or tapered discontinuation in trials, symptoms occurring more often with duloxetine than placebo included dizziness, headache, nausea, diarrhea, paresthesia, irritability, vomiting, insomnia, anxiety, hyperhidrosis, and fatigue. It further cites spontaneous reports across SSRIs/SNRIs of dysphoric mood, agitation, sensory disturbances such as electric-shock sensations (paresthesias), confusion, emotional lability, hypomania, tinnitus, and seizures on discontinuation, particularly when abrupt; some have been severe. The label directs that a gradual, prescriber-managed dose reduction rather than abrupt cessation is recommended whenever possible, and that if intolerable symptoms occur the prescriber may consider resuming the previous dose and then tapering more slowly. This is not in the boxed warning (the boxed warning concerns suicidal thoughts and behaviors). Do not stop duloxetine on your own — any change is a prescriber-managed decision.

The elimination half-life of duloxetine is about 12 hours (typically 8 to 17 hours) — that is how long the body takes to clear half of a dose. Duloxetine has no pharmacologically active major metabolites, so nothing extends its effect; however, the half-life is prolonged roughly 3-fold in people with moderate liver impairment (cirrhosis), and it runs somewhat longer in older adults. Half-life is not the same as how long a drug test can detect the drug, and it varies with age, kidney and liver function.

It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run duloxetine against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.

We track 2 duloxetine-containing products in the U.S.: Cymbalta and Drizalma Sprinkle. They are the same active ingredient; they differ in form, manufacturer, price and FDA recall record.

Across the brands we track, duloxetine is currently marketed as capsule, delayed release, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.

We do not currently list a generic-labelled duloxetine product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.

The FDA's Enforcement database lists at least 5 recall records whose product description mentions duloxetine. The most recent: DULOXETINE D/R (Jun 22, 2026). A recall applies to specific lots, not to the drug as a whole — check the record for the affected lot numbers.

For mood and anxiety, duloxetine works gradually — some effect in 1 to 2 weeks, the full effect usually in about 4 to 6 weeks. When it is used for nerve pain, some people notice pain relief sooner, often within the first weeks, though it can also take several weeks to build.

Alcohol: the FDA label says to avoid alcohol — see the alcohol section above for what it actually says. This is what the FDA label and our cited sources say — it is not a complete list. Your pharmacist can check your own combination.

The most common everyday side effects, per MedlinePlus, are nausea, dry mouth, constipation or diarrhea, decreased appetite and weight changes, tiredness or drowsiness, sweating (including night sweats), and dizziness. Some people also notice trouble sleeping and sexual side effects such as reduced libido or delayed orgasm. Nausea in particular tends to be worst in the first days to weeks and often eases as your body adjusts. These are usually mild, but tell your prescriber if any are severe or persistent. This is not a complete list.

Get emergency help right away for signs of serotonin syndrome — MedlinePlus lists agitation, hallucinations, fever, fast or irregular heartbeat, and severe muscle stiffness — and for a serious allergic reaction (rash, hives, blistering, trouble breathing, or swelling of the face or throat) or seizures. Call your doctor promptly for signs of liver injury: loss of appetite, unusual bruising or bleeding, itching, pain in the upper right abdomen, yellowing of the skin or eyes, or dark urine. The FDA label warns that 'Hepatic failure, sometimes fatal, has been reported' and that Cymbalta 'should not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease.' Cymbalta carries an FDA boxed warning that antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults under 25, especially early in treatment or after a dose change — watch for new or worsening depression, agitation, or thoughts of self-harm and seek help immediately. Because it's an SNRI it can also raise blood pressure and increase bleeding risk, especially with NSAIDs, aspirin, or blood thinners.

Cymbalta is prescribed for long-term conditions like depression, anxiety, diabetic nerve pain, and fibromyalgia, and many people take it for years under a doctor's care. The main issues to monitor over time are blood pressure (the FDA label says it 'should be measured prior to initiating treatment and periodically measured throughout treatment'), liver health (avoid heavy alcohol use and tell your doctor about any liver disease), and bleeding risk if you also use NSAIDs, aspirin, or anticoagulants. A known trade-off of longer use is that stopping can be harder, so any decision to continue or taper is managed by your prescriber. This isn't a full safety profile — review your individual risks with your doctor.

Early side effects like nausea usually appear within the first days of starting or after a dose increase and commonly settle within the first couple of weeks as your body adjusts, according to how MedlinePlus describes these effects. For the intended benefit, MedlinePlus notes 'It may take 1 to 4 weeks or longer before you feel the full benefit of duloxetine,' so mild side effects can precede the improvement you're waiting for. If a side effect is severe, or hasn't eased after a few weeks, contact your prescriber rather than stopping on your own.

Do not stop Cymbalta on your own — this is prescriber-managed, and the FDA label states 'A gradual reduction in dosage rather than abrupt cessation is recommended.' Stopping abruptly can trigger a discontinuation syndrome. MedlinePlus warns: 'If you suddenly stop taking duloxetine, you may experience withdrawal symptoms such as nausea; vomiting; diarrhea; anxiety; dizziness; tiredness; headache; pain, burning, numbness, or tingling in the hands or feet; irritability; difficulty falling asleep or staying asleep; sweating; and nightmares.' The tingling, burning, and electric-shock-like sensations some people call 'brain zaps' fall in this category. If you want to come off Cymbalta, ask your doctor to plan a slow, supervised taper.

Duloxetine (brand name Cymbalta) is an SNRI antidepressant with several FDA-approved uses: major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathy (nerve pain from diabetes), fibromyalgia, and chronic musculoskeletal pain such as ongoing low back pain and osteoarthritis pain. It works by raising serotonin and norepinephrine levels, which affect both mood and how the body processes pain.

Yes — nerve pain from diabetes (diabetic peripheral neuropathy) is one of duloxetine's FDA-approved uses, so it's a labeled treatment, not off-label, for that condition. It's also used off-label for other types of nerve pain, such as chemotherapy-induced neuropathy. Its dual action on pain-signaling chemicals is why it treats certain chronic pain conditions even in people who aren't depressed.

Stopping duloxetine suddenly can cause discontinuation symptoms — dizziness, nausea, headache, irritability, and "brain zaps" (electric-shock sensations). The FDA label advises tapering the dose gradually rather than stopping all at once. Duloxetine also carries the antidepressant boxed warning about increased suicidal thoughts in people under 25.